Samsung is preparing to remove one of its newer health tracking features from Galaxy Watches in the United States. The company has confirmed that the Vascular Load tool will be discontinued later this month and replaced with a new feature called Blood Pressure Trend.
The update is expected to arrive alongside Samsung Health 7.0 and One UI 9 Watch. While the feature is disappearing for US users, it is expected to remain available in other regions.
Samsung Is Ending Vascular Load in the US
Vascular Load first debuted with the Galaxy Watch 8 during Galaxy Unpacked 2025. The feature used heart rate data to estimate changes in blood volume and provide users with additional insights into their cardiovascular wellness.
Samsung has now started notifying users through the Samsung Health app that the feature will no longer be available in the United States after late July.
Once it is removed, Vascular Load data will no longer appear in the Samsung Health app.
What Happens to Existing Data?
Users who want to keep their previous Vascular Load records should download their data before the feature is discontinued.
Samsung says users can access their saved information by opening the Samsung Health app, navigating to Samsung Health Settings, and selecting Samsung Health Information to export their existing records.
Blood Pressure Trend Will Replace It
(techxara.com)
To replace vascular load, Samsung is introducing Blood Pressure Trend, a new wellness feature expected to launch with its upcoming Galaxy Watch models.
Unlike Vascular Load, which focused on changes in blood volume using heart rate measurements, Blood Pressure Trend is designed to monitor blood pressure over time and display long-term trends. It will also provide personalized wellness tips to help users maintain healthy habits.
To use the feature, Samsung says users must first calibrate their Galaxy Watch with a compatible blood pressure cuff. The watch will require recalibration every 28 days to maintain accurate readings.
Samsung also notes that the blood pressure trend is intended for wellness purposes only and is not designed to diagnose, monitor, or treat medical conditions.
Why Is Samsung Making This Change?
Samsung has not officially explained why it is removing Vascular Load from the US market.
However, many users online believe the decision could be related to regulatory requirements from the U.S. Food and Drug Administration (FDA). Some industry observers suggest the approval process for health-related features may have influenced Samsung’s decision.
At this stage, these claims remain speculation, and Samsung has not confirmed whether FDA compliance played any role in the feature’s removal.
final thought;
Samsung is replacing the Vascular Load feature on Galaxy Watches in the United States with Blood Pressure Trend as part of its upcoming software updates. While the new tool offers long-term blood pressure tracking and personalized wellness guidance, it works differently and requires regular calibration using a blood pressure cuff.
Samsung has not shared the reason behind the change, so reports linking the decision to FDA requirements should be treated as speculation until the company provides an official explanation.
FAQ Section
1. Is Samsung removing Vascular Load from all Galaxy Watches?
No. At the moment, Samsung has only confirmed that Vascular Load will be removed for users in the United States.
2. What is replacing Vascular Load?
Samsung is introducing Blood Pressure Trend, a new health feature that monitors blood pressure over time and provides wellness insights.
3. Do I need additional equipment for Blood Pressure Trend?
Yes. Samsung says users must calibrate the Galaxy Watch with a compatible blood pressure cuff and repeat the calibration every 28 days.
4. Can I keep my Vascular Load history?
Yes. Samsung allows users to download their existing Vascular Load data through the Samsung Health app before the feature is removed.
5. Why is Samsung removing Vascular Load?
Samsung has not officially explained the reason. Reports suggesting the decision is related to FDA regulations remain unconfirmed.